BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36313783)

  • 1. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
    Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
    Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
    Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
    Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.
    Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q
    Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma.
    Yang S; Liu L; Liu X; Li X; Zheng Y; Ren Z; Wang R; Wang Y; Li Q
    Medicine (Baltimore); 2023 Nov; 102(46):e36046. PubMed ID: 37986397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel aging-associated lncRNA signature for predicting prognosis in osteosarcoma.
    He Y; Huang X; Ma Y; Yang G; Cui Y; Lv X; Zhao R; Jin H; Tong Y; Zhang X; Li J; Peng M
    Sci Rep; 2024 Jan; 14(1):1386. PubMed ID: 38228673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma.
    Lin Z; He Y; Wu Z; Yuan Y; Li X; Luo W
    Sci Rep; 2023 Sep; 13(1):15059. PubMed ID: 37700003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
    Li G; Lei J; Xu D; Yu W; Bai J; Wu G
    Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.
    Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H
    Mutat Res; 2023; 827():111828. PubMed ID: 37437507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
    Hong X; Fu R
    PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
    Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
    Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.